Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery
NCT ID: NCT02373722
Last Updated: 2018-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2015-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Impact of Video Discharge Instructions for Mohs Surgery Post-Operative Care
NCT02970435
Strategies to Promote Skin Health
NCT03237013
Impact of Videos on Patient Anxiety and Satisfaction
NCT03485937
Reducing Skin Cancer Risk in Childhood Cancer Survivors
NCT02046811
Teach-back Method on Patient Satisfaction and Adherence to Wound Care Regimen
NCT04377971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To create a web application which will educate dermatologic surgery patients prior to their operations with educational videos.
SECONDARY OBJECTIVES:
I. To create and evaluate a web based system to send wound care instructions to patients by text message after their operation.
II. Qualitative comments from participants and research staff concerning the feasibility of this approach and the use of Fitbit activity trackers as a means to monitor movement restriction.
III. The rate of adverse events.
OUTLINE: Patients are randomized to 1 of 4 groups.
GROUP I: Patients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly twice daily (BID) to the wound area.
GROUP II: Patients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area.
GROUP III: Patients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are.
GROUP IV: Patients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area.
After completion of study, patients are followed up at 1 week.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (video, text message)
Patients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly BID to the wound area.
Mohs Surgery
Undergo Mohs surgery
Internet-Based Intervention
Watch website application based educational video
Telephone-Based Intervention
Receive text messages
Educational Intervention
Watch website application based educational video
Exercise Intervention
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Applied to the wound area
Questionnaire Administration
Ancillary studies
Survey Administration
Ancillary studies
Group II (educational video)
Patients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area
Mohs Surgery
Undergo Mohs surgery
Internet-Based Intervention
Watch website application based educational video
Educational Intervention
Watch website application based educational video
Exercise Intervention
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Applied to the wound area
Questionnaire Administration
Ancillary studies
Survey Administration
Ancillary studies
Group III (text message)
Patients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are.
Mohs Surgery
Undergo Mohs surgery
Telephone-Based Intervention
Receive text messages
Exercise Intervention
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Applied to the wound area
Questionnaire Administration
Ancillary studies
Survey Administration
Ancillary studies
Group IV (control)
Patients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area.
Mohs Surgery
Undergo Mohs surgery
Exercise Intervention
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Applied to the wound area
Questionnaire Administration
Ancillary studies
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mohs Surgery
Undergo Mohs surgery
Internet-Based Intervention
Watch website application based educational video
Telephone-Based Intervention
Receive text messages
Educational Intervention
Watch website application based educational video
Exercise Intervention
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Applied to the wound area
Questionnaire Administration
Ancillary studies
Survey Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed
* The subject is able to complete the study and comply with study instructions, including attending all study visits
* The patient has a cell phone capable of receiving text messages
Exclusion Criteria
* Inability to complete all study-related visits
* Non-English speaking patients
* The patient cannot receive text messages
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Pearce
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-00217
Identifier Type: REGISTRY
Identifier Source: secondary_id
CCCWFU 01714
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00028840
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.